Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Boehringer Ingelheim
Moodys
Merck
AstraZeneca

Last Updated: January 27, 2023

TYLENOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drug patent expirations by year for TYLENOL
Drug Sales Revenue Trends for TYLENOL

See drug sales revenues for TYLENOL

Recent Clinical Trials for TYLENOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hamilton Health Sciences CorporationPhase 3
McMaster UniversityPhase 3
Baylor College of MedicinePhase 4

See all TYLENOL clinical trials

US Patents and Regulatory Information for TYLENOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc TYLENOL acetaminophen SUPPOSITORY;RECTAL 017756-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ortho Mcneil Pharm TYLENOL W/ CODEINE acetaminophen; codeine phosphate TABLET;ORAL 085056-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc TYLENOL acetaminophen TABLET, EXTENDED RELEASE;ORAL 019872-002 Jan 11, 2001 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ortho Mcneil Pharm TYLENOL W/ CODEINE NO. 3 acetaminophen; codeine phosphate CAPSULE;ORAL 087422-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ortho Mcneil Pharm TYLENOL W/ CODEINE acetaminophen; codeine phosphate TABLET;ORAL 085056-003 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ortho Mcneil Pharm TYLENOL W/ CODEINE NO. 4 acetaminophen; codeine phosphate CAPSULE;ORAL 087421-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc TYLENOL acetaminophen SUPPOSITORY;RECTAL 017756-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TYLENOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc TYLENOL acetaminophen TABLET, EXTENDED RELEASE;ORAL 019872-001 Jun 8, 1994 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc TYLENOL acetaminophen TABLET, EXTENDED RELEASE;ORAL 019872-001 Jun 8, 1994 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc TYLENOL acetaminophen TABLET, EXTENDED RELEASE;ORAL 019872-001 Jun 8, 1994 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TYLENOL

See the table below for patents covering TYLENOL around the world.

Country Patent Number Title Estimated Expiration
Ireland 62831 Orally sustained-release acetaminophen formulation and process to obtain it See Plans and Pricing
European Patent Office 0305051 ORALLY SUSTAINED-RELEASE ACETAMINOPHEN FORMULATION AND PROCESS TO OBTAIN IT See Plans and Pricing
Australia 611704 See Plans and Pricing
Japan 2720932 See Plans and Pricing
Germany 3880762 See Plans and Pricing
South Africa 8805460 See Plans and Pricing
New Zealand 225402 ORAL SUSTAINED RELEASE ACETAMINOPHEN FORMULATIONS See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Dow
McKesson
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.